Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-000341
Filing Date
2021-01-08
Accepted
2021-01-08 19:57:00
Documents
2
Period of Report
2021-01-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-50903.html 4  
1 PRIMARY DOCUMENT marketforms-50903.xml 4 7172
2 POA DOCUMENT poa.htm EX-24 3148
  Complete submission text file 0001214659-21-000341.txt   11802
Mailing Address TORREYPINES THERAPEUTICS, INC. 11085 NORTH TORREY PINES RD, STE 300 LA JOLLA CA 92037
Business Address 858-623-5665
REED VICKIE S (Reporting) CIK: 0001405637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 21518820

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations